Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Tuberculosis (Edinb) ; 140: 102345, 2023 05.
Artículo en Inglés | MEDLINE | ID: mdl-37116235

RESUMEN

CD11b+Gr-1low cells that are increased in the lungs of a Mycobacterium (M) tuberculosis-infection mouse model have the characteristics of monocytic (M)-myeloid-derived suppressor cells (MDSCs) and harbor M.tuberculosis. Interestingly, a high number of M-MDSCs have also been observed in skin lesions of patients with lepromatous leprosy. We hypothesized that CD11b+Gr-1low cells might be involved in the pathogenesis of leprosy, as they are in tuberculosis. In the current study, we investigated the issue of whether CD11b+Gr-1low cells accumulate in Mycobacterium (M) leprae-induced granulomas of the footpad skin of nude mice. Our results show that CD11b+Gr-1low cells began to accumulate in the 7-month-old M.leprae-induced granulomas and were replaced by other leukocytes, including CD11b+Gr-1high over time during M.leprae infections. CD11b + Gr-1low cells expressed the surface markers of M-MDSC, Ly6Chigh and Ly6Glow. In addition, CD11b+Gr-1low cells have the nuclei of a mononuclear cell type and expressed higher levels of arginase 1 (Arg1) and inducible NO synthetase (iNOS). Furthermore, they showed a higher infection rate by M.leprae. Taken together, our results indicate that the inoculation with M.leprae induced an accumulation of CD11b + Gr-1low at a relatively early stage, 7-month-old M.leprae-induced granulomas, and that CD11b+Gr-1low have the characteristics of M-MDSC and may act as a reservoir for M.leprae.


Asunto(s)
Mycobacterium tuberculosis , Células Supresoras de Origen Mieloide , Tuberculosis , Ratones , Animales , Células Supresoras de Origen Mieloide/metabolismo , Células Supresoras de Origen Mieloide/patología , Ratones Desnudos , Mycobacterium tuberculosis/metabolismo , Tuberculosis/metabolismo , Granuloma/inducido químicamente , Granuloma/metabolismo , Antígeno CD11b/metabolismo
2.
PLoS One ; 14(10): e0224239, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31648257

RESUMEN

Mycobacterium indicus pranii (MIP) known for its immunotherapeutic potential against leprosy and tuberculosis is undergoing various clinical trials and also simultaneously being studied in animal models to get insight into the mechanistic details contributing to its protective efficacy as a vaccine candidate. Studies have shown potential immunomodulatory properties of MIP, the most significant being the ability to induce strong Th1 type of response, enhanced expression of pro-inflammatory cytokines, activation of APCs and lymphocytes, elicitation of M.tb specific poly-functional T cells. All of these form crucial components of host-immune response during M.tb infection. Also, MIP was found to be potent inducer of autophagy in macrophages which resulted in enhanced clearance of M.tb from MIP and M.tb co-infected cells. Hence, we further examined the component/s of MIP responsible for autophagy induction. Interestingly, we found that MIP lipids and DNA were able to induce autophagy but not the protein fraction. LAM being one of the crucial components of mycobacterial cell-wall lipids and possessing the ability of immunomodulation; we isolated LAM from MIP and did a comparative study with M.tb-LAM. Stimulation with MIP-LAM resulted in significantly high secretion of pro-inflammatory cytokines and displayed high autophagy inducing potential in macrophages as compared to M.tb-LAM. Treatment with MIP-LAM enhanced the co-localization of M.tb within the phago-lysosomes and increased the clearance of M.tb from the infected macrophages. This study describes LAM to be a crucial component of MIP which has significant contribution to its immunotherapeutic efficacy against TB.


Asunto(s)
Autofagia , Inmunomodulación/efectos de los fármacos , Lipopolisacáridos/farmacología , Macrófagos/patología , Mycobacterium tuberculosis/inmunología , Tuberculosis/inmunología , Animales , Macrófagos/efectos de los fármacos , Macrófagos/inmunología , Macrófagos/microbiología , Ratones , Ratones Endogámicos C57BL , Células RAW 264.7 , Tuberculosis/metabolismo , Tuberculosis/microbiología
3.
Cell Physiol Biochem ; 35(4): 1276-88, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25721573

RESUMEN

BACKGROUND: The early secreted antigenic target 6-kDa protein (ESAT-6) of Mycobacterium tuberculosis (Mtb) not only acts as a key player for virulence but also exhibits a strong immunotherapeutic potential against Mtb. However, little is known about the molecular basis for its potential in immunotherapy. The present study was designed to unravel the role of miRNA-155 in ESAT-6-mediated enhancement of host immunity and apoptosis in macrophages. METHODS: Lentivirus-mediated miR-155 sponge and miR-155 and SOCS1 overexpression vectors were developed in macrophages. TLR2- or p65-specific siRNA knockdown was employed to silence TLR2 or p65. Quantitative polymerase chain reaction and western blotting analyses were performed to determine mRNA and protein expression levels, respectively. Macrophage apoptosis was analyzed by flow cytometry. RESULTS: ESAT-6 significantly increased miR-155 expression, which was dependent on TLR2/NF-κB activation in macrophages. Induced expression of miRNA-155 was required for the ESAT-6-mediated protective immune response and macrophage apoptosis. ESAT-6 promoted macrophage apoptosis by targeting the miR-155-SOCS1 pathway. The differential expression levels of TLR2, BIC, and SOCS1 were involved in regulating the immune response in human peripheral blood mononuclear cells of patients with active tuberculosis (TB) and latent TB (LTB). CONCLUSION: ESAT-6 promotes apoptosis of macrophages via targeting the miRNA155-SOCS1 interaction.


Asunto(s)
Antígenos Bacterianos/farmacología , Apoptosis/efectos de los fármacos , MicroARNs/metabolismo , Mycobacterium tuberculosis/metabolismo , Proteínas Supresoras de la Señalización de Citocinas/metabolismo , Tuberculosis/patología , Animales , Antígenos Bacterianos/genética , Antígenos Bacterianos/metabolismo , Línea Celular , Humanos , Interleucina-6/genética , Interleucina-6/metabolismo , Leucocitos Mononucleares/metabolismo , Macrófagos/citología , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Ratones , Interferencia de ARN , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/genética , Proteínas Recombinantes/farmacología , Proteínas Supresoras de la Señalización de Citocinas/genética , Receptor Toll-Like 2/antagonistas & inhibidores , Receptor Toll-Like 2/genética , Receptor Toll-Like 2/metabolismo , Factor de Transcripción ReIA/antagonistas & inhibidores , Factor de Transcripción ReIA/genética , Factor de Transcripción ReIA/metabolismo , Tuberculosis/metabolismo , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/metabolismo
4.
Glycobiology ; 22(8): 1118-27, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22534567

RESUMEN

Mannose-capped lipoarabinomannan (ManLAM) is a complex lipoglycan abundantly present in the Mycobacterium tuberculosis cell envelope. Many biological properties have been ascribed to ManLAM, from directly interacting with the host and participating in the intracellular survival of M. tuberculosis, to triggering innate and adaptive immune responses, including the activation of CD1b-restricted T cells. Due to its structural complexity, ManLAM is considered a heterogeneous population of molecules which may explain its different biological properties. The presence of various modifications such as fatty acids, succinates, lactates, phosphoinositides and methylthioxylose in ManLAM have proven to correlate directly with its biological activity and may potentially be involved in the interactions between CD1b and the T cell population. To further delineate the specific ManLAM epitopes involved in CD1b-restricted T cell recognition, and their potential roles in mediating immune responses in M. tuberculosis infection, we established a method to resolve ManLAM into eight different isoforms based on their different isoelectric values. Our results show that a ManLAM isoform with an isoelectric value of 5.8 was the most potent in stimulating the production of interferon-γ in different CD1b-restricted T-cell lines. Compositional analyses of these isoforms of ManLAM revealed a direct relationship between the overall charge of the ManLAM molecule and its capacity to be presented to T cells via the CD1 compartment.


Asunto(s)
Antígenos CD1/metabolismo , Lipopolisacáridos/metabolismo , Manosa/metabolismo , Mycobacterium tuberculosis/metabolismo , Linfocitos T/metabolismo , Tuberculosis/metabolismo , Antígenos CD1/inmunología , Proliferación Celular , Células Dendríticas/citología , Células Dendríticas/inmunología , Células Dendríticas/metabolismo , Humanos , Interferón gamma/metabolismo , Punto Isoeléctrico , Lepra/inmunología , Lepra/metabolismo , Lipopolisacáridos/inmunología , Mycobacterium tuberculosis/inmunología , Mycobacterium tuberculosis/aislamiento & purificación , Fosfatos/metabolismo , Isoformas de Proteínas , Succinatos/metabolismo , Linfocitos T/inmunología , Tuberculosis/inmunología , Tuberculosis/microbiología
5.
Annu Rev Genet ; 40: 469-86, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17094741

RESUMEN

Host genetic factors play a major role in determining differential susceptibility to major infectious diseases of humans, such as malaria, HIV/AIDS, tuberculosis, and invasive pneumococcal disease. Progress in identifying the relevant genetic loci has come from a variety of approaches. Most convincing associations have been identified by case-control studies assessing biologically plausible candidate genes. All six of the genes that have a major effect on infectious disease susceptibility in humans have been identified in this way. However, recently genome-wide linkage analysis of affected sibling pairs has identified susceptibility loci for chronic infections such as leprosy and chronic hepatitis B virus persistence. Other approaches used successfully have included assessment in humans of the homologues of susceptibility genes mapped and identified in murine models. However, the great majority of susceptibility loci remain to be identified and the advent of large-scale genome-wide association scans offers a new approach to defining many of these.


Asunto(s)
Enfermedades Transmisibles/genética , Predisposición Genética a la Enfermedad , Síndrome de Inmunodeficiencia Adquirida/genética , Síndrome de Inmunodeficiencia Adquirida/metabolismo , Animales , Enfermedades Transmisibles/metabolismo , Ligamiento Genético , Genoma Humano , Hepatitis B Crónica/genética , Hepatitis B Crónica/metabolismo , Humanos , Lepra/genética , Lepra/metabolismo , Malaria/genética , Malaria/metabolismo , Ratones , Transducción de Señal , Tuberculosis/genética , Tuberculosis/metabolismo
6.
Clin Infect Dis ; 41 Suppl 7: S408-15, 2005 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-16237639

RESUMEN

Toll-like receptor 2 (TLR2) is a member of the TLR family, which plays a central role in the innate immune response to a wide variety of microorganisms. Animal studies have shown that TLR2-knockout mice are more susceptible to septicemia due to Staphylococcus aureus and Listeria monocytogenes, meningitis due to Streptococcus pneumoniae, and infection with Mycobacterium tuberculosis, suggesting that functional TLR2 polymorphisms may impair host response to a certain spectrum of microbial pathogens. In humans, 2 polymorphisms in the exon part of TLR2, which attenuate receptor signaling, enhance the risk of acute severe infections, tuberculosis, and leprosy. Because gram-positive bacteria have became the first cause of severe infections, including septic shock, knowledge of the role that alteration or lack of TLR2 function plays in the pathogenesis of infectious diseases could contribute to the design of new therapeutic strategies, including prevention, pharmacological intervention, and vaccine development.


Asunto(s)
Infecciones por Bacterias Grampositivas/genética , Polimorfismo Genético , Receptor Toll-Like 2/genética , Proteínas Adaptadoras Transductoras de Señales/metabolismo , Animales , Infecciones por Bacterias Grampositivas/inmunología , Infecciones por Bacterias Grampositivas/metabolismo , Humanos , Inmunidad Innata , Ligandos , Ratones , Ratones Noqueados , Mycobacterium , Fosfatidilinositol 3-Quinasas/metabolismo , Polimorfismo de Nucleótido Simple/genética , Choque Séptico/metabolismo , Choque Séptico/prevención & control , Transducción de Señal , Receptor Toll-Like 2/deficiencia , Receptor Toll-Like 2/metabolismo , Tuberculosis/genética , Tuberculosis/metabolismo
7.
Trop Med Int Health ; 4(7): 493-8, 1999 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10470341

RESUMEN

The concentration of cortisol in a tissue is regulated by a reversible enzyme 'shuttle' that can deactivate cortisol by converting it to cortisone, or activate cortisone by converting it to cortisol. The activity of this shuttle, and the direction in which it operates, is regulated by numerous factors including cytokines. This results in large swings in the effective cortisol concentration in sites of inflammation at different phases of an inflammatory response. Thus changes in local cortisol concentration can be largely independent of circulating cortisol levels. The relevant shuttle enzymes are present in skin, blood vessels and nervous tissue, and inhibition of the enzymes in skin enhances the local anti-inflammatory effect of cortisol. We therefore suggest that changes in the activity or direction of action of the shuttle in leprosy lesions may predispose to reactions, requiring exogenous steroid supplements to regain control of the inflammation.


Asunto(s)
Hidrocortisona/metabolismo , Lepra/inmunología , Lepra/metabolismo , 11-beta-Hidroxiesteroide Deshidrogenasas , Animales , Citocinas/metabolismo , Femenino , Humanos , Hidrocortisona/farmacología , Hidroxiesteroide Deshidrogenasas/metabolismo , Lepra/tratamiento farmacológico , Macrófagos/inmunología , Macrófagos/metabolismo , Embarazo , Complicaciones Infecciosas del Embarazo/inmunología , Complicaciones Infecciosas del Embarazo/metabolismo , Piel/metabolismo , Linfocitos T/inmunología , Linfocitos T/metabolismo , Tuberculosis/metabolismo
9.
Soc Appl Bacteriol Symp Ser ; 25: 10S-22S, 1996.
Artículo en Inglés | MEDLINE | ID: mdl-8972115
11.
Am Rev Respir Dis ; 139(3): 774-8, 1989 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-2466430

RESUMEN

A survey of the fractionated lipids of Mycobacterium tuberculosis H37Rv was conducted using rabbit antiserum raised to homologous and heterologous mycobacteria. One minor, highly apolar lipid was resolved by Florisil column chromatography, which reacted preferentially to anti-M. tuberculosis H37Rv rabbit antibodies. Other chromatographic properties, i.e., thin-layer chromatographic mobility and staining properties, suggested an analog of the phenolic glycolipid of Mycobacterium leprae. Preliminary results in the application of the glycolipid to tuberculous populations in northeast Thailand suggest a usefulness in screening for tuberculosis.


Asunto(s)
Lípidos/análisis , Mycobacterium tuberculosis/metabolismo , Antígenos Bacterianos/inmunología , Cromatografía en Capa Delgada , Ensayo de Inmunoadsorción Enzimática , Glucolípidos/análisis , Glucolípidos/inmunología , Lípidos/inmunología , Mycobacterium tuberculosis/inmunología , Pruebas Serológicas , Coloración y Etiquetado , Tuberculosis/diagnóstico , Tuberculosis/metabolismo
13.
Int J Lepr Other Mycobact Dis ; 47(3): 484-6, 1979 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-573749

RESUMEN

A method is described for the extraction of mycolic acid from lepromatous leprosy tissues and from tuberculous tissues and its identification by thin layer chromatography. Verification of the mycolic acid extracted and separated by thin layer chromatography was accomplished by infrared spectroscopy. Although the presence of mycolic acid in tissues is not, in itself, diagnostic for leprosy, its demonstration in biopsy tissues might be a useful additional qualitative test if used in conjunction with clinical evidence of the disease.


Asunto(s)
Lepra/metabolismo , Ácidos Micólicos/metabolismo , Animales , Cromatografía en Capa Delgada , Humanos , Espectrofotometría Infrarroja , Tuberculosis/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA